Emanuele Alì

5PUBLICATIONS
19CO-AUTHORS
Molecular targetsRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 27, 2025
Recent Advances in Androgen Receptor Pathway Inhibitors for Castration-Sensitive Prostate Cancer.

Andrea Lancia, Marco Oderda, Federico Camilli

|Jul 29, 2025
Lung Stereotactic Body Radiotherapy (SBRT): Challenging Scenarios and New Frontiers.

Serena Badellino, Francesco Cuccia, Marco Galaverni

|Nov 26, 2024
Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Alessio Bruni, Vieri Scotti, Maria Alessia Zerella

|Jan 21, 2022
Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer.

Gianluca Ingrosso, Emanuele Alì, Simona Marani

|May 18, 2020
Salvage radiotherapy in patients affected by oligorecurrent pelvic nodal prostate cancer.

G Ingrosso, C Mariucci, M V Tenti

Pageof 1

Frequent Collaborators

2 joint publications

Maria Alessia Zerella

2 joint publications

Francesco Cuccia

2 joint publications

Antonio Pontoriero

2 joint publications

Paolo Borghetti